Exelixis, Inc. (EXEL)

43.96 -1.48 (-3.26%) USD  |  NASDAQ  |  Jan 16, 16:00
43.98 +0.02 (+0.05%) After-Hours: 20:00
More

Exelixis Preferred Securities out of Shareholders Equity (Quarterly)

Preferred Securities out of Shareholders Equity (Quarterly) Chart

View Preferred Securities out of Shareholders Equity (Quarterly) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Securities out of Shareholders Equity (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --
Aldeyra Therapeutics, Inc. --
Natera, Inc. --
Merck & Co., Inc. --